Log In
Print
BCIQ
Print
Print this Print this
 

FI6

  Manage Alerts
Collapse Summary General Information
Company Humabs BioMed S.A.
DescriptionHuman mAb targeting all 16 types of haemagglutinin subtypes of influenza A, binding and neutralising both Group 1 and 2 human and animal viruses
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationInfluenza virus
Indication DetailsTreat influenza
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today